Kenji Yoshida

3.4k total citations · 1 hit paper
78 papers, 2.5k citations indexed

About

Kenji Yoshida is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Kenji Yoshida has authored 78 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 13 papers in Physiology and 11 papers in Surgery. Recurrent topics in Kenji Yoshida's work include Pluripotent Stem Cells Research (6 papers), Asthma and respiratory diseases (6 papers) and CRISPR and Genetic Engineering (5 papers). Kenji Yoshida is often cited by papers focused on Pluripotent Stem Cells Research (6 papers), Asthma and respiratory diseases (6 papers) and CRISPR and Genetic Engineering (5 papers). Kenji Yoshida collaborates with scholars based in Japan, United States and Czechia. Kenji Yoshida's co-authors include Fumitake Toki, Keiko Shiratori, Shinichiro Watanabe, Naoaki Hayashi, Tadashi Takeuchi, Hideyuki Okano, Masaya Nakamura, Shinya Yamanaka, Kyoko Miura and Satoshi Nori and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Kenji Yoshida

73 papers receiving 2.4k citations

Hit Papers

Chronic pancreatitis caus... 1995 2026 2005 2015 1995 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Yoshida Japan 18 1.2k 997 845 584 257 78 2.5k
Jochen Neuhaus Germany 25 391 0.3× 345 0.3× 756 0.9× 151 0.3× 206 0.8× 105 2.2k
Shigeru B. H. Ko Japan 29 1.3k 1.2× 735 0.7× 2.1k 2.5× 528 0.9× 181 0.7× 76 3.7k
Enric Condom Spain 37 919 0.8× 230 0.2× 1.7k 2.0× 294 0.5× 252 1.0× 106 3.6k
Boél De Paepe Belgium 27 281 0.2× 257 0.3× 1.3k 1.6× 651 1.1× 147 0.6× 110 2.5k
Christian Faul United States 38 634 0.5× 402 0.4× 2.9k 3.4× 260 0.4× 273 1.1× 89 7.3k
Stephen Lee United States 26 571 0.5× 151 0.2× 948 1.1× 242 0.4× 466 1.8× 80 2.8k
Athanasios Didangelos United Kingdom 26 376 0.3× 197 0.2× 889 1.1× 130 0.2× 348 1.4× 39 2.4k
Keiichi Enjyoji United States 37 547 0.5× 139 0.1× 1.1k 1.3× 418 0.7× 159 0.6× 80 4.9k
Shannon E. Dunn Canada 24 316 0.3× 200 0.2× 1.2k 1.4× 277 0.5× 176 0.7× 55 3.1k
Katsunori Fujii Japan 33 374 0.3× 874 0.9× 1.3k 1.6× 292 0.5× 204 0.8× 179 3.8k

Countries citing papers authored by Kenji Yoshida

Since Specialization
Citations

This map shows the geographic impact of Kenji Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Yoshida more than expected).

Fields of papers citing papers by Kenji Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Yoshida. The network helps show where Kenji Yoshida may publish in the future.

Co-authorship network of co-authors of Kenji Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Yoshida. A scholar is included among the top collaborators of Kenji Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Yoshida. Kenji Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuchiya, Hiroyuki, et al.. (2023). NEAT1–SOD2 Axis Confers Sorafenib and Lenvatinib Resistance by Activating AKT in Liver Cancer Cell Lines. Current Issues in Molecular Biology. 45(2). 1073–1085. 13 indexed citations
2.
Namiki, Jun, Sayuri Suzuki, Shinsuke Shibata, et al.. (2022). Chitinase-like protein 3: A novel niche factor for mouse neural stem cells. Stem Cell Reports. 17(12). 2704–2717. 3 indexed citations
3.
Morizane, Asuka, et al.. (2021). Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application. Journal of Parkinson s Disease. 12(3). 871–884. 13 indexed citations
4.
Doi, Daisuke, Tetsuhiro Kikuchi, Megumi Ikeda, et al.. (2020). Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease. Nature Communications. 11(1). 3369–3369. 223 indexed citations
6.
Tanaka, Tetsuji, Kenji Yoshida, Takashi Ueyama, et al.. (2014). Estrogen-Dependent Proteolytic Cleavage of Semaphorin 4D and Plexin-B1 Enhances Semaphorin 4D-Induced Apoptosis during Postnatal Vaginal Remodeling in Pubescent Mice. PLoS ONE. 9(5). e97909–e97909. 8 indexed citations
7.
Yoshida, Kenji, Eri Tanaka, Kohei Togami, et al.. (2013). Dexmedetomidine decreases the oral mucosal blood flow. British Journal of Oral and Maxillofacial Surgery. 51(8). 928–931. 14 indexed citations
8.
Yamaguchi, Hideaki, Tao Yu, Yumi Kidachi, et al.. (2011). Selective toxicity of glycyrrhetinic acid against tumorigenic r/m HM-SFME-1 cells is potentially attributed to downregulation of glutathione. Biochimie. 93(7). 1172–1178. 9 indexed citations
9.
Horie, Yoshifumi, Akira Meguro, Masao Ôta, et al.. (2009). Association of TLR4 polymorphisms with Behcet's disease in a Korean population. Lara D. Veeken. 48(6). 638–642. 41 indexed citations
10.
Endo, Sohei, Kenichi Watanabe, Shin Suzuki, et al.. (2006). Intra-arterial Chemo-radiation for Advanced Laryngeal Cancer. Koutou (THE LARYNX JAPAN). 18(2). 78–83. 4 indexed citations
11.
Fukuda, Youichi, et al.. (2001). Hormonal Effects of Z-350, Possessing Steroid 5 a-Reductase Inhibitory and a ι-Adrenoceptor Antagonistic Actions, in the Rat. The Japanese Journal of Pharmacology. 86(3). 323–328. 3 indexed citations
12.
Yoshida, Kenji, et al.. (2000). Radiographic studies of the wrist and elbow in cerebral palsy. Journal of Orthopaedic Science. 5(3). 268–274. 4 indexed citations
13.
Mori, Toyoki, Tadayoshi Takeuchi, M. Ohura, et al.. (1998). Pranidipine, a new 1, 4-dihydropyridine calcium channel blocker, enhances cyclic GMP-independent nitric oxide-induced relaxation of the rat aorta. Molecular and Cellular Biochemistry. 178(1-2). 335–343. 16 indexed citations
14.
Yoshida, Kenji, et al.. (1995). Discovery and Development of Novel Pyrazolecarboxamide Acaricides.. NIPPON KAGAKU KAISHI. 865–874. 2 indexed citations
15.
Yoshida, Kenji, et al.. (1994). Antiallergic Effect of ZCR-2060: Antihistaminic Action. The Japanese Journal of Pharmacology. 66(1). 87–94. 6 indexed citations
16.
Yoshida, Kenji, et al.. (1994). Antihistaminic and antiallergic effects of ZCR-2060 in in vitro and in vivo studies.. The Japanese Journal of Pharmacology. 64. 310–310. 2 indexed citations
17.
Yanagawa, Hiroshi, Kenji Yoshida, Chikako Torigoe, et al.. (1993). Protein anatomy: functional roles of barnase module.. Journal of Biological Chemistry. 268(8). 5861–5865. 43 indexed citations
18.
Inagaki, Naoki, et al.. (1992). Mechanisms for Glucocorticoid Inhibition of Immediate Hypersensitivity Reactions in Rats. The Japanese Journal of Pharmacology. 59(1). 77–87. 7 indexed citations
19.
Yoshida, Kenji, et al.. (1987). [N-acetyl-beta-D-glucosaminidase (NAG) activity in human semen: its relation to gamma-glutamyl transpeptidase (gamma-GTP) activity in seminal plasma and reproductive tissues, and relation between seminal mucoprotein concentration and seminal NAG, and gamma-GTP activities].. PubMed. 33(7). 1054–9. 2 indexed citations
20.
Hashimoto, Masayo, et al.. (1979). METABOLISM OF A NEW ANALGESIC AGENT, dl-erythro-1-PHENYL-2-(o-CHLOROPHENYL)-2-[4-(p-METHOXYBENZYL)-1-PIPERAZINYL]ETHANOL DIHYDROCHLORIDE, IN RATS. Drug Metabolism and Disposition. 7(6). 435–441. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026